These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 23509915)
21. Development of immunopharmacotherapy against drugs of abuse. Meijler MM; Matsushita M; Wirsching P; Janda KD Curr Drug Discov Technol; 2004 Jan; 1(1):77-89. PubMed ID: 16472221 [TBL] [Abstract][Full Text] [Related]
22. Vaccines against drugs of abuse: a viable treatment option? Kantak KM Drugs; 2003; 63(4):341-52. PubMed ID: 12558457 [TBL] [Abstract][Full Text] [Related]
28. Investigations into the efficacy of multi-component cocaine vaccines. Kimishima A; Olson ME; Janda KD Bioorg Med Chem Lett; 2018 Sep; 28(16):2779-2783. PubMed ID: 29317163 [TBL] [Abstract][Full Text] [Related]
29. Ethical Implications in Vaccine Pharmacotherapy for Treatment and Prevention of Drug of Abuse Dependence. Carfora A; Cassandro P; Feola A; La Sala F; Petrella R; Borriello R J Bioeth Inq; 2018 Mar; 15(1):45-55. PubMed ID: 29350320 [TBL] [Abstract][Full Text] [Related]
30. Altered methamphetamine place conditioning in mice vaccinated with a succinyl-methamphetamine-tetanus-toxoid vaccine. Haile CN; Kosten TA; Shen XY; O'Malley PW; Winoske KJ; Kinsey BM; Wu Y; Huang Z; Lykissa ED; Naidu N; Cox JA; Arora R; Kosten TR; Orson FM Am J Addict; 2015 Dec; 24(8):748-55. PubMed ID: 26584468 [TBL] [Abstract][Full Text] [Related]
31. Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines. Duryee MJ; Bevins RA; Reichel CM; Murray JE; Dong Y; Thiele GM; Sanderson SD Vaccine; 2009 May; 27(22):2981-8. PubMed ID: 19428909 [TBL] [Abstract][Full Text] [Related]
32. The frequency of early-activated hapten-specific B cell subsets predicts the efficacy of vaccines for nicotine dependence. Laudenbach M; Tucker AM; Runyon SP; Carroll FI; Pravetoni M Vaccine; 2015 Nov; 33(46):6332-9. PubMed ID: 26409811 [TBL] [Abstract][Full Text] [Related]
33. Ethical issues in using a cocaine vaccine to treat and prevent cocaine abuse and dependence. Hall W; Carter L J Med Ethics; 2004 Aug; 30(4):337-40. PubMed ID: 15289512 [TBL] [Abstract][Full Text] [Related]
35. Reasons for stimulant use among Latino gay men in San Francisco: a comparison between methamphetamine and cocaine users. Díaz RM; Heckert AL; Sánchez J J Urban Health; 2005 Mar; 82(1 Suppl 1):i71-8. PubMed ID: 15738318 [TBL] [Abstract][Full Text] [Related]
36. Is immunotherapy an opportunity for effective treatment of drug addiction? Zalewska-Kaszubska J Vaccine; 2015 Nov; 33(48):6545-51. PubMed ID: 26432911 [TBL] [Abstract][Full Text] [Related]
37. Development of a therapeutic vaccine for the treatment of cocaine addiction. Fox BS Drug Alcohol Depend; 1997 Dec; 48(3):153-8. PubMed ID: 9449013 [TBL] [Abstract][Full Text] [Related]
38. Anti-drug vaccines to treat substance abuse. Kinsey BM; Jackson DC; Orson FM Immunol Cell Biol; 2009; 87(4):309-14. PubMed ID: 19333250 [TBL] [Abstract][Full Text] [Related]
39. Agents in development for the management of cocaine abuse. Gorelick DA; Gardner EL; Xi ZX Drugs; 2004; 64(14):1547-73. PubMed ID: 15233592 [TBL] [Abstract][Full Text] [Related]